CINECA IRIS Institutional Research Information System

SCHIRRIPA, MARTA Statistiche

SCHIRRIPA, MARTA  

DIP. DI RICERCA TRASLAZIONALE E DELLE NUOVE TECNOLOGIE IN MEDICINA E CHIRURGIA - disattivato (attivo dal 19/09/2012 al 31/12/2019)  

Mostra records
Risultati 1 - 20 di 32 (tempo di esecuzione: 0.03 secondi).
Titolo Data di pubblicazione Autore(i) File
The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer 1-gen-2020 Fanelli, G. N.; Dal Pozzo, C. A.; Depetris, I.; Schirripa, M.; Brignola, S.; Biason, P.; Balistreri, M.; Dal Santo, L.; Lonardi, S.; Munari, G.; Loupakis, F.; Fassan, M.
Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trial 1-gen-2020 Pasqualetti, G.; Schirripa, M.; Dochy, E.; Fassan, M.; Ziranu, P.; Puzzoni, M.; Scartozzi, M.; Alberti, G.; Lonardi, S.; Zagonel, V.; Monzani, F.; Loupakis, F.
Benefit from anti-EGFRs in RAS and BRAF wild-type metastatic transverse colon cancer: A clinical and molecular proof of concept study 1-gen-2019 Cremolini, Chiara; Benelli, Matteo; Fontana, Elisa; Pagani, Filippo; Rossini, Daniele; Fucà, Giovanni; Busico, Adele; Conca, Elena; Di Donato, Samantha; Loupakis, Fotios; Schirripa, Marta; Lonardi, Sara; Borelli, Beatrice; Ongaro, Elena; Eason, Katherine; Morano, Federica; Casagrande, Mariaelena; Fassan, Matteo; Sadanandam, Anguraj; De Braud, Filippo; Falcone, Alfredo; Pietrantonio, Filippo
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients 1-gen-2019 Del Re, Marzia; Cinieri, Saverio; Michelucci, Angela; Salvadori, Stefano; Loupakis, Fotios; Schirripa, Marta; Cremolini, Chiara; Crucitta, Stefania; Barbara, Cecilia; Di Leo, Angelo; Latiano, Tiziana Pia; Pietrantonio, Filippo; Di Donato, Samantha; Simi, Paolo; Passardi, Alessandro; De Braud, Filippo; Altavilla, Giuseppe; Zamagni, Claudio; Bordonaro, Roberto; Butera, Alfredo; Maiello, Evaristo; Pinto, Carmine; Falcone, Alfredo; Mazzotti, Valentina; Morganti, Riccardo; Danesi, Romano
Early modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenib 1-gen-2019 Schirripa, Marta; Borelli, Beatrice; D'Aurizio, Romina; Lubrano, Simone; Cremolini, Chiara; Zucchelli, Gemma; Antoniotti, Carlotta; Marmorino, Federica; Prete, Alessandra Anna; Murgioni, Sabina; Bergamo, Francesca; Zagonel, Vittorina; Tuccoli, Andrea; Marranci, Andrea; Rizzo, Milena; Tedeschi, Lorena; Magnoni, Letizia; Falcone, Alfredo; Loupakis, Fotios; Poliseno, Laura
Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: the MOMA trial 1-gen-2019 Cremolini, C; Marmorino, F; Bergamo, F; Aprile, G; Salvatore, L; Masi, G; Dell'Aquila, E; Antoniotti, C; Murgioni, S; Allegrini, G; Borelli, B; Gemma, D; Casagrande, M; Granetto, C; Delfanti, S; Di Donato, S; Schirripa, M; Sensi, E; Tonini, G; Lonardi, S; Fontanini, G; Boni, L; Falcone, A.
Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand-Foot Skin Reaction in Metastatic Colorectal Cancer Patients Treated With Regorafenib 1-gen-2018 Suenaga, Mitsukuni; Schirripa, Marta; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Cremolini, Chiara; Antoniotti, Carlotta; Borelli, Beatrice; Mashima, Tetsuo; Okazaki, Satoshi; Berger, Martin D; Miyamoto, Yuji; Gopez, Roel; Barzi, Afsaneh; Lonardi, Sara; Yamaguchi, Toshiharu; Falcone, Alfredo; Loupakis, Fotios; Lenz, Heinz-Josef
NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients 1-gen-2018 Schirripa, Marta; Zhang, Wu; Yang, Dongyun; Cao, Shu; Okazaki, Satoshi; Loupakis, Fotios; Berger, Martin D; Ning, Yan; Miyamoto, Yuji; Suenaga, Mitsukuni; Alberti, Giulia; West, Jordan D; Lonardi, Sara; Khoukaz, Taline; Bergamo, Francesca; Battaglin, Francesca; Antoniotti, Carlotta; Falcone, Alfredo; Stintzing, Sebastian; Heinemann, Volker; Lenz, Heinz-Josef
Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer 1-gen-2018 Suenaga, Mitsukuni; Schirripa, Marta; Cao, Shu; Zhang, Wu; Yang, Dongyun; Cremolini, Chiara; Lonardi, Sara; Bergamo, Francesca; Ning, Yang; Yamamoto, Noriko; Okazaki, Satoshi; Berger, Martin D.; Miyamoto, Yuji; Gopez, Roel; Barzi, Afsaneh; Yamaguchi, Toshiharu; Stintzing, Sebastian; Heinemann, Volker; Loupakis, Fotios; Falcone, Alfredo; Lenz, Heinz-Josef
Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO 1-gen-2018 Dell'Aquila, E; Cremolini, C; Zeppola, T; Lonardi, S; Bergamo, F; Masi, G; Stellato, M; Marmorino, F; Schirripa, M; Urbano, F; Ronzoni, M; Tomasello, G; Zaniboni, A; Racca, P; Buonadonna, A; Allegrini, G; Fea, E; Di Donato, S; Chiara, S; Tonini, G; Tomcikova, D; Boni, L; Falcone, A; Santini, D
Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study 1-gen-2018 Hanna, Diana L; Loupakis, Fotios; Yang, Dongyun; Cremolini, Chiara; Schirripa, Marta; Li, Meng; Matsusaka, Satoshi; Berger, Martin D; Miyamoto, Yuji; Zhang, Wu; Ning, Yan; Antoniotti, Carlotta; Salvatore, Lisa; Moran, Miriana; Zeger, Gary; Astrow, Stephanie H; Falcone, Alfredo; Lenz, Heinz-Josef
Prognostic Value of Thyroid Hormone Ratios in Patients With Advanced Metastatic Colorectal Cancer Treated With Regorafenib: The TOREADOR Study 1-gen-2018 Schirripa, Marta; Pasqualetti, Giuseppe; Giampieri, Riccardo; Scartozzi, Mario; Lonardi, Sara; Rumanò, Laura; Bergamo, Francesca; Stragliotto, Silvia; Murgioni, Sabina; Alberti, Giulia; Rizzato, Mario Domenico; Prete, Alessandra Anna; Puzzoni, Marco; Pusceddu, Valeria; Ziranu, Pina; Pani, Fabiana; Mariotti, Stefano; Zagonel, Vittorina; Monzani, Fabio; Loupakis, Fotios
Autophagy-related polymorphisms predict hypertension in patients with metastatic colorectal cancer treated with FOLFIRI and bevacizumab: Results from TRIBE and FIRE-3 trials 1-gen-2017 Berger, Martin D; Yamauchi, Shinichi; Cao, Shu; Hanna, Diana L.; Sunakawa, Yu; Schirripa, Marta; Matsusaka, Satoshi; Yang, Dongyun; Groshen, Susan; Zhang, Wu; Ning, Yan; Okazaki, Satoshi; Miyamoto, Yuji; Suenaga, Mitsukuni; Lonardi, Sara; Cremolini, Chiara; Falcone, Alfredo; Heinemann, Volker; Loupakis, Fotios; Stintzing, Sebastian; Lenz, Heinz Josef
Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer 1-gen-2017 Suenaga, M; Schirripa, M; Cao, S; Zhang, W; Yang, D; Murgioni, S; Rossini, D; Marmorino, F; Mennitto, A; Ning, Y; Okazaki, S; Berger, M D; Miyamoto, Y; Gopez, R; Barzi, A; Yamaguchi, T; Loupakis, F; Lenz, H-J
Impact of genetic variations in the MAPK signaling pathway on outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: Data from FIRE-3 and TRIBE trials 1-gen-2017 Berger, M. D.; Stintzing, S.; Heinemann, V.; Yang, D.; Cao, S.; Sunakawa, Y.; Ning, Y.; Matsusaka, S.; Okazaki, S.; Miyamoto, Y.; Suenaga, M.; Schirripa, M.; Soni, S.; Zhang, W.; Falcone, A.; Loupakis, F.; Lenz, H. -. J.
Single nucleotide polymorphisms in the IGF-IRS pathway are associated with outcome in mCRC patients enrolled in the FIRE-3 trial 1-gen-2017 Schirripa, Marta; Zhang, Wu; Heinemann, Volker; Cao, Shu; Okazaki, Satoshi; Yang, Dongyun; Loupakis, Fotios; Berger, Martin D.; Ning, Yan; Miyamoto, Yuji; Suenaga, Mitsukuni; Gopez, Roel F.; West, Jordan D.; Hanna, Diana; Barzi, Afsaneh; Falcone, Alfredo; Stintzing, Sebastian; Lenz, Heinz-Josef
Tandem repeat variation near the HIC1 (hypermethylated in cancer 1) promoter predicts outcome of oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer 1-gen-2017 Okazaki, Satoshi; Schirripa, Marta; Loupakis, Fotios; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Berger, Martin D.; Miyamoto, Yuji; Suenaga, Mitsukuni; Iqubal, Syma; Barzi, Afsaneh; Cremolini, Chiara; Falcone, Alfredo; Battaglin, Francesca; Salvatore, Lisa; Borelli, Beatrice; Helentjaris, Timothy G.; Lenz, Heinz josef
TRIBE-2: A phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group 1-gen-2017 Cremolini, Chiara; Marmorino, Federica; Loupakis, Fotios; Masi, Gianluca; Antoniotti, Carlotta; Salvatore, Lisa; Schirripa, Marta; Boni, Luca; Zagonel, Vittorina; Lonardi, Sara; Aprile, Giuseppe; Tamburini, Emiliano; Ricci, Vincenzo; Ronzoni, Monica; Pietrantonio, Filippo; Valsuani, Chiara; Tomasello, Gianluca; Passardi, Alessandro; Allegrini, Giacomo; DI DONATO, Samantha; Santini, Daniele; Falcone, Alfredo
Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical study 1-gen-2017 Cremolini, Chiara; Pietrantonio, F; Tomasello, G; Dadduzio, V; Morett, R; Morano, F; Schirripa, Marta; Antoniotti, Carlotta; Fucà, G; Bergamo, F; Rossini, Daniele; Nichetti, F; Ziampiri, S; Ghidini, M; Marmorino, Federica; Prisciandaro, M; Falcone, Alfredo; De Braud, F; Loupakis, Fotios; Lonardi, S.
Clinical significance of tlr1 i602s polymorphism for patients with metastatic colorectal cancer treated with folfiri plus bevacizumab 1-gen-2016 Okazaki, Satoshi; Loupakis, Fotios; Stintzing, Sebastian; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Sunakawa, Yu; Stremitzer, Stefan; Matsusaka, Satoshi; Berger, Martin D.; Parekh, Anish; West, Jordan D.; Miyamoto, Yuji; Suenaga, Mitsukuni; Schirripa, Marta; Cremolini, Chiara; Falcone, Alfredo; Heinemann, Volker; Depaolo, R. William; Lenz, Heinz Josef